Hepatocellular carcinoma [PDF]
, 2018 Liver cancer is the second leading cause of cancer-related deaths globally and has an incidence of approximately 850,000 new cases per year. Hepatocellular carcinoma (HCC) represents approximately 90% of all cases of primary liver cancer.
Gores, Gregory +6 more
core +1 more source
INTERVENTIONAL SURGERY IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER
Вестник урологии, 2015 During the period from 2004 to 2014, prostatic artery embolization was performed in 59 patients with benign prostatic hyperplasia (BPH) and superselective chemoembolization in 36 patients with prostate cancer.
A. I. Neymark +4 more
doaj +1 more source
Hepatic Oncology, 2018 Hepatocellular carcinoma (HCC) is the sixth most common type of malignancy. Several therapies are available for HCC and are determined by stage of presentation, patient clinical status and liver function.
Nikolaos Galanakis +4 more
doaj +1 more source
Hepatic outflow obstruction created by balloon occlusion of the hepatic vein: induced hepatic hemodynamic changes and the therapeutic applications of hepatic venous occlusion with a balloon catheter in interventional radiology. [PDF]
, 2005 Hepatic outflow obstruction created by balloon occlusion of the hepatic vein induces characteristic angiographic findings in the occluded area: prolonged enhancement on hepatogram followed by reversed portal opacification on the hepatic arteriogram and ...
Hiraki, Takao, Kanazawa, Susumu
core +1 more source
Radiology Case Reports, 2019 Severe reactions to modern iodinated contrasts are uncommon. Breakthrough reactions in the setting of pretreatment with corticosteroids are even rarer.
Robert Pugh, MS +3 more
doaj +1 more source
A concise review of updated global guidelines for the management of hepatocellular carcinoma: 2017-2024 [PDF]
Journal of Liver CancerMany guidelines for hepatocellular carcinoma (HCC) have been published and are regularly updated worldwide. HCC management involves a broad range of treatment options and requires multidisciplinary care, resulting in significant heterogeneity in ...
Hyunjae Shin, Su Jong Yu
doaj +1 more source
Biliary complications after transcatheter arterial chemoembolization for hepatocellular carcinoma
International Journal of Gastrointestinal Intervention, 2020 Transarterial chemoembolization (TACE) is considered an effective procedure for liver malignancy. Although the majority of TACE related complications can be treated conservatively, appropriate therapeutic interventions, such as percutaneous/endoscopic ...
Yoon Suk Lee, Kyung-Ah Kim
doaj +1 more source
Sorafenib as a feasible therapeutic option in haemophiliacs with hepatocellular carcinoma [PDF]
, 2009 hepatocellular carcinoma, haemophilia ...
BRUERA, G +7 more
core +1 more source
Fatores de Risco para o Desenvolvimento de Síndrome Pós-Quimioembolização após Quimioembolização Hepática para Tratamento de Hepatocarcinoma [PDF]
, 2018 Introduction: Hepatic transarterial chemoembolization is a widely used technique for the treatment of hepatocellular carcinoma. The most common complication of this procedure is postembolization syndrome.
Bilhim, T +4 more
core